A detailed history of Capital Analysts, LLC transactions in Viatris Inc stock. As of the latest transaction made, Capital Analysts, LLC holds 431 shares of VTRS stock, worth $5,603. This represents 0.0% of its overall portfolio holdings.

Number of Shares
431
Previous 383 12.53%
Holding current value
$5,603
Previous $4,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.32 - $12.13 $495 - $582
48 Added 12.53%
431 $5,000
Q2 2024

Aug 14, 2024

SELL
$10.05 - $12.02 $201 - $240
-20 Reduced 4.96%
383 $4,000
Q1 2024

May 14, 2024

BUY
$11.27 - $13.53 $45 - $54
4 Added 1.0%
403 $5,000
Q4 2023

Jan 30, 2024

SELL
$8.77 - $10.85 $14,812 - $18,325
-1,689 Reduced 80.89%
399 $4,000
Q3 2023

Nov 13, 2023

SELL
$9.59 - $11.35 $642 - $760
-67 Reduced 3.11%
2,088 $21,000
Q2 2023

Aug 11, 2023

BUY
$9.02 - $10.29 $36 - $41
4 Added 0.19%
2,155 $22,000
Q1 2023

May 05, 2023

SELL
$9.2 - $12.26 $478 - $637
-52 Reduced 2.36%
2,151 $20,000
Q4 2022

Feb 08, 2023

SELL
$8.72 - $11.56 $514 - $682
-59 Reduced 2.61%
2,203 $24,000
Q3 2022

Nov 14, 2022

SELL
$8.48 - $11.13 $1,670 - $2,192
-197 Reduced 8.01%
2,262 $19,000
Q2 2022

Aug 12, 2022

SELL
$9.95 - $12.27 $348 - $429
-35 Reduced 1.4%
2,459 $26,000
Q1 2022

May 12, 2022

SELL
$9.81 - $15.4 $7,318 - $11,488
-746 Reduced 23.02%
2,494 $27,000
Q4 2021

Feb 10, 2022

BUY
$12.09 - $14.68 $16,248 - $19,729
1,344 Added 70.89%
3,240 $44,000
Q3 2021

Nov 04, 2021

BUY
$13.25 - $15.13 $5,445 - $6,218
411 Added 27.68%
1,896 $26,000
Q2 2021

Nov 15, 2021

SELL
$12.97 - $16.15 $9,416 - $11,724
-726 Reduced 32.84%
1,485 $21,000
Q2 2021

Aug 05, 2021

BUY
$12.97 - $16.15 $3,385 - $4,215
261 Added 13.38%
2,211 $32,000
Q1 2021

May 17, 2021

SELL
$13.59 - $18.54 $41,694 - $56,880
-3,068 Reduced 61.14%
1,950 $27,000
Q4 2020

Feb 16, 2021

BUY
$14.3 - $18.74 $71,757 - $94,037
5,018 New
5,018 $94,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.